tirzepatide and kidney damage Mounjaro seems good for protection in those with type 2 #diabetes, as expected. The benefits appear greater for those with kidney disease Data from Apperloo EM, et al. Diabetes Care. 2025;doi:10.2337/dc24-1773 Not currently a kidney therapy.

The full effects of semaglutide and similar GLP-1 agonists are still being explored by scientists

When asked which treatment they would prefer if both were equally effective, about two-thirds of patients lean towards the tirzepatide, versus providers, [for whom] it was exactly the opposite way, Dr

Few people have seen the inner workings of federal and state food assistance programs as deeply as todays guest, Kevin Concannon, former Undersecretary of Food, Nutrition and Consumer services in the US Department of Agriculture, under President Obama

We gradually increase the dosage over time to allow the body to adjust and minimize potential gastrointestinal side effects